Event Abstract

In vivo evaluation of the influence of bioceramics architectural features on the angiogenesis and bone formation

  • 1 Ecole Nationale Supérieure des Mines, Centre Ingénierie et Santé (CIS-EMSE) CNRS:UMR 5307, France
  • 2 Université Paris VII - Paris Diderot - Ecole Nationale Vétérinaire d'Alfort, Bioingénierie et Biomécanique Ostéo-Articulaire (B2OA) CNRS : UMR7052, France

Introduction: The reconstruction of large bone defects constitutes an important clinical problem, and none of the current approaches were proved to be optimal. Calcium phosphates (CaP) bioceramics have been extensively employed to this purpose. Unfortunately, CaP bioceramics produced from conventional manufacturing processes suffer from sample-to-sample variations or design limitations[1] ; so many detrimental points which prevent to understand the relation between architecture and cell fate, and consequently to improve the ceramic design. In this context, we developed a flexible and robust bioceramics manufacturing process, and investigated the influence of the bioceramic architectural features on the angiogenesis and osteogenesis.

Material and Methods: Bioceramic manufacturing: Bioceramics computer-aided design (CAD) models comprising 4 unidirectional cylindrical pores, were created (Fig. 1). Hydroxyapatite bioceramics manufacturing was carried out by slurry impregnation of an organic template, manufactured from a 3D printer, followed by heat treatments (i.e. debinding, sintering).

In vivo evaluation: Bioceramics were subcutaneously implanted in nude mice up to 30 days for angiogenesis study and 60 days for osteogenesis study. For the latter, bioceramics were coated with rhBMP-2 and/or seeded with human mesenchymal stem cells prior to implantation. Prior to histological analysis, blood vessels, cells nuclei and neo-formed bone were stained with ink, Stevenel’s blue and Van Gieson's picrofuchsin, respectively.

Results: Fig. 1 displays CAD and µ-tomography X images of the ceramics and demonstrates the robustness and reliability of the manufacturing process.

Optical microscope images (Fig. 2) as well as histological evaluation of angiogenesis reveal blood vessel growth inside channels with time, independently to their diameters.More interestingly, even if large blood vessels (Ø > 50 µm) are significantly more numerous in large pores (840 µm), section surface of blood vessels normalized according to channel sections, is constant whatever the channel diameter is. Finally, osteogenic evaluation of rhBMP-2-coated-bioceramics revealed a significant increase in bone formation within the small pores (150 µm).

Discussion: These preliminary data revealed a significant effect of the pore size on angiogenesis and osteogenesis. They suggest that large blood vessel (Ø>50µm), which have the capacity to propagate deeper in the scaffold than the capillaries (Ø<25µm), are more numerous in the large pores (840 µm). In opposition, capillaries are significantly more present in small pores (150 µm) where new bone formation occurs preferentially: this would imply that capillaries play a major role in bone ingrowth.

Conclusion: From these results, a strategy to improve efficiently the reconstruction of large bone defects would be to design personalized implants with a gradient of porosity, from large pores at the periphery to small ones at its centre.

References:
[1] Bouet, G., et al., In Vitro Three-Dimensional Bone Tissue Models: From Cells to Controlled and Dynamic Environment. Tissue Engineering Part B: Reviews, 2014

Keywords: Bone Regeneration, Calcium phosphate, Rapid prototyping, 3D scaffold

Conference: 10th World Biomaterials Congress, Montréal, Canada, 17 May - 22 May, 2016.

Presentation Type: General Session Oral

Topic: Biomaterials in musculoskeletal orthopeadics and tissues

Citation: Charbonnier B, Grandjean A, Deschepper M, Bernache-Assollant D, Petite H and Marchat D (2016). In vivo evaluation of the influence of bioceramics architectural features on the angiogenesis and bone formation. Front. Bioeng. Biotechnol. Conference Abstract: 10th World Biomaterials Congress. doi: 10.3389/conf.FBIOE.2016.01.02010

Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters.

The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.

Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.

For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions.

Received: 27 Mar 2016; Published Online: 30 Mar 2016.